RP
Insider
Rhonda Janice Pacheco
President, U.S. Business UnitRhonda Janice Pacheco (President, U.S. Business Unit) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Takeda Pharmaceutical Company Limited (TAK). The largest single filing was $289K of TAK (16,901 sh × $17.10, as filed), executed Aug 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$289K
shares × price, as filed
Last traded
Aug 10
Filed Aug 12
Median ADV $57.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $289K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
TAKRecent filings
TAKSALE
Takeda Pharmaceutical Company Limited
View filing →
$289K16,901 sh × $17.10
Exec Aug 10
Filed Aug 12 · 9:53 PM ET